ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1154

Poly(I:C)-Induced Cell Death Of Synovial Fibroblasts via an Unknown dsRNA Receptor

Jörg Hamann1, Paul P. Tak2 and Olga N. Karpus3, 1Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Departments of Experimental Immunology and Internal Medicine, GlaxoSmithKline U.K. and Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 31Departments of Experimental Immunology and Internal Medicine, Academic Medical Center, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Apoptosis and fibroblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) is characterized by hyperplasia of the synovial tissue due to local proliferation of stromal and recruitment of inflammatory immune cells. Accumulation of synovial fibroblasts likely is due to an imbalance between cell proliferation, survival and death. Both cytosolic dsRNA receptors, MDA5 and RIG-I, can initiate pro-apoptotic signalling in a variety of cell types. In animal models of cancer and multiple sclerosis, treatment with dsRNA ligands causes apoptosis of effector cells and ameliorates disease. We showed that fibroblast-like synoviocytes (FLS) from RA synovial tissue are equipped with functional cytosolic dsRNA receptors. We have studied the consequences of stimulation with dsRNA on the survival of FLS. 

Methods:

FLS from arthritis patients were stimulated with poly(I:C) or 3pRNA complexed with fugene (FG) for intracellular uptake. Stimulation was confirmed by RT-PCR of dsRNA response genes (MDA5, RIG-I and CXCL10). Cell death of FLS after triggering of dsRNA sensors was detected by flow-cytometric analysis using annexin V/PI staining. Changes in protein expression of anti- and pro-apoptotic genes were analyzed by Western blot. Knockdown of MDA5, RIG-I and their adaptor proteins was performed using SMART pool siRNAs.

Results:

dsRNA response genes, including MDA5, RIG-I and CXCL10 were similarly induced after 16 h stimulation of RA FLS with either 3pRNA or  poly(I:C), complexed with FG. However, 3pRNA + FG treatment of FLS caused about 15% of cell death after 48 h, whereas poly(I:C) + FG treatment induced up to 75% cell death. Surprisingly, we did not find differences in the expression of pro- and anti-apoptotic proteins between cells stimulated with 3pRNA + FG or poly(I:C) + FG. siRNA knockdown of MDA5, a known receptor for poly(I:C), did not effect poly(I:C) + FG stimulation on dsRNA response genes, whereas knockdown of RIG-I, a known receptor for 3pRNA, completely abrogated the response to 3pRNA + FG. Knockdown of downstream adaptor proteins IPS, STING and TRIF did not have any effect on dsRNA response genes after poly(I:C) +  FG stimulation. 

Conclusion:

Stimulation of RA FLS with artificial dsRNA poly(I:C), but not 3pRNA induced apoptosis of FLS. We confirmed that 3pRNA is recognized by the dsRNA sensor RIG-I. In contrast, intracellular recognition of poly(I:C) in FLS does not involve MDA5 and the adapter proteins IPS, STING and TRIF, suggesting the existence of a different recognition mechanism.


Disclosure:

J. Hamann,
None;

P. P. Tak,
None;

O. N. Karpus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polyic-induced-cell-death-of-synovial-fibroblasts-via-an-unknown-dsrna-receptor/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology